AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 22 min read$OKLO

DeWitte Jacob sold $995K of OKLO (indirect holdings)

DeWitte Jacob (Co-Founder, CEO) sold 14,814 indirectly-held shares of Oklo Inc. (OKLO) at $67.15 ($0.99M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DeWitte Jacob
Published Jun 2, 2026, 9:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$OKLO
Neutral
medium confidence
Mentioned
$OKLO
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OKLONeutralLow
01

Why it matters

The disclosure provides a datapoint on insider liquidity but does not, by itself, confirm changes in fundamentals.

02

Market read

OKLO receives a routine insider-selling update; any trading impact is likely sentiment-driven and small due to the 10b5-1 framing.

03

What to watch

Traders may overreact to insider selling; the key is whether there are concurrent operational/financing catalysts not mentioned in this Form 4.

Relevance 6/10Novelty 4/10Timing: After-hours/next-session read-through of June 1 insider sale disclosure filed June 2

Background

SEC Form 4 discloses an officer/director/10% owner transaction; 10b5-1 plans are pre-set to reduce trading on material nonpublic information.

Company-level read

Ticker impact

$OKLONeutralMedium confidence
Context

Oklo co-founder/CEO and 10% owner DeWitte Jacob sold $994.8K of OKLO shares via a pre-arranged 10b5-1 plan on June 1.

Expected impact

Near-term impact likely muted; may slightly pressure sentiment if traders overweight insider sales.

Evidence & confidence

The filing is a routine insider transaction and explicitly references a pre-arranged 10b5-1 plan, which reduces the probability of immediate new negative information.

Market effects

Sector

Minimal; this is company-specific insider liquidity rather than a sector catalyst.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled diversification rather than bearish expectations.

Key entities

  • issuer
    Oklo Inc.

    Subject of the insider transaction disclosure (Form 4).

  • insider
    DeWitte Jacob

    Co-founder, CEO, officer/director, and 10% owner who sold shares.

Read at source← All news

Related articles

AUG 9
$OKLOMed

Oklo’s Groves Research Reactor Achieves First Criticality

Oklo (NYSE: OKLO) said its Groves Isotope Test Reactor reached first criticality on private land, supported by DOE Reactor Pilot Program authorization. Los Alamos’ ZiaCore microreactor also achieved zero-power criticality. ARC Clean Technology (ARC) outlined plans for ARC-100 at INL and a term sheet for Turkey. Holtec, Entergy and Hyundai will evaluate SMR-300 projects in Gulf states.

neutronbytes.com6 min
AUG 7
$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.

yahoo.com10 min
AUG 7
$OKLOMed

Oklo Stock Attempts a Turnaround, but Technical Barriers Remain as It Releases Q2 2026 Financial Results

Oklo reported Q2 2026 revenue of $1.2 million, above analysts’ ~$83,800 estimate, but posted a $0.28 per-share loss versus a ~$0.16 consensus. Net loss widened to $48.5 million from $24.7 million a year earlier. The company ended the quarter with about $3 billion in cash and marketable securities and said its Groves Isotope Test Reactor achieved first criticality.

fxleaders.com6 min
AUG 7
$OKLOMedAI 8/10

Oklo reports $1.21M Q2 revenue, $1.6B cash as Aurora milestones advance

Oklo Inc. (NYSE: OKLO) reported Q2 2026 revenue of $1.21M versus a $126,250 analyst estimate and an EPS loss of $(0.28) versus an estimated $(0.16). The company said it ended the quarter with $1.6B cash and expects 2026 operating cash flow of $120M to $150M and capex of $400M to $500M. It also advanced Aurora regulatory steps and said its Groves reactor reached first criticality.

scanx.trade7 min